FIDSON Stock Overview
Manufactures and distributes pharmaceutical products in Nigeria. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
Fidson Healthcare Plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₦14.50 |
| 52 Week High | ₦19.20 |
| 52 Week Low | ₦12.40 |
| Beta | 0.31 |
| 1 Month Change | -2.36% |
| 3 Month Change | -16.91% |
| 1 Year Change | -11.04% |
| 3 Year Change | 155.20% |
| 5 Year Change | 414.52% |
| Change since IPO | 406.35% |
Recent News & Updates
Recent updates
Shareholder Returns
| FIDSON | NG Pharmaceuticals | NG Market | |
|---|---|---|---|
| 7D | 0% | 1.8% | 2.5% |
| 1Y | -11.0% | -7.3% | 51.2% |
Return vs Industry: FIDSON underperformed the NG Pharmaceuticals industry which returned -7.3% over the past year.
Return vs Market: FIDSON underperformed the NG Market which returned 51.2% over the past year.
Price Volatility
| FIDSON volatility | |
|---|---|
| FIDSON Average Weekly Movement | 6.1% |
| Pharmaceuticals Industry Average Movement | 6.2% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in NG Market | 8.5% |
| 10% least volatile stocks in NG Market | 3.1% |
Stable Share Price: FIDSON has not had significant price volatility in the past 3 months compared to the NG market.
Volatility Over Time: FIDSON's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 650 | Fidelis Ayebae | fidson.com |
Fidson Healthcare Plc manufactures and distributes pharmaceutical products in Nigeria. The company operates in three segments: Over-the-Counter, Ethical Products, and Consumer Healthcare Product. It offers drugs, infusions, and injectables.
Fidson Healthcare Plc Fundamentals Summary
| FIDSON fundamental statistics | |
|---|---|
| Market cap | ₦33.28b |
| Earnings (TTM) | ₦3.48b |
| Revenue (TTM) | ₦72.41b |
9.6x
P/E Ratio0.5x
P/S RatioIs FIDSON overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FIDSON income statement (TTM) | |
|---|---|
| Revenue | ₦72.41b |
| Cost of Revenue | ₦42.88b |
| Gross Profit | ₦29.52b |
| Other Expenses | ₦26.05b |
| Earnings | ₦3.48b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.52 |
| Gross Margin | 40.77% |
| Net Profit Margin | 4.80% |
| Debt/Equity Ratio | 154.8% |
How did FIDSON perform over the long term?
See historical performance and comparisonDividends
4.1%
Current Dividend Yield40%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 09:33 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Fidson Healthcare Plc is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Oladipo James | Afrinvest (West Africa) Limited |
| null null | CardinalStone Partners Limited |
| null null | Meristem Securities Limited |